Anti-Cathepsin-L Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the propeptide domain of human Cathepsin-L (CTSL, P07711), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential
UniProt
P07711
Size
100ug
Cat. #
RP2CathepsinL

In stock

SKU
RP-CathepsinL

Options

As low as: $130.00

Target Overview

Cathepsin-L (CTSL, EC 3.4.22.15, UniProt P07711) is a lysosomal cysteine protease of the papain superfamily that mediates intracellular protein degradation and extracellular matrix remodeling. Synthesized as procathepsin L, the 333-residue zymogen undergoes proteolytic activation in the acidic lysosomal compartment to generate the mature enzyme. Cathepsin-L exhibits broad substrate specificity and functions at neutral pH as a major elastinase when secreted. It plays essential roles in antigen processing for MHC class II presentation, thyroglobulin proteolysis and thyroid hormone release, prohormone processing in neuroendocrine cells, and bone remodeling. In thymic cortical epithelial cells, Cathepsin-L regulates CD4+ T cell positive selection through generation of MHCII-bound peptide ligands. The enzyme also cleaves collagen XVIII to produce the anti-angiogenic fragment endostatin. Researchers study Cathepsin-L in contexts ranging from autophagy and lysosomal storage disorders to cancer invasion, immune regulation, and viral entry mechanisms, particularly its role in SARS-CoV-2 spike protein processing.

Background

Cathepsin-L functions as a critical regulator of both intracellular proteostasis and extracellular remodeling. Within lysosomes, it mediates bulk protein turnover essential for cellular homeostasis, while secreted forms accumulate in the extracellular space of antigen-presenting cells to degrade matrix components during inflammation. The enzyme's elastolytic activity at neutral pH distinguishes it from many lysosomal proteases and underlies its role in tissue remodeling. In thymus, Cathepsin-L processes the invariant chain and generates peptide repertoires that shape the CD4+ T cell receptor repertoire during positive selection. The enzyme is also required for cardiac morphogenesis, hair follicle cycling, and epidermal differentiation through mechanisms involving both proteolytic and potentially non-proteolytic functions.

Recent work has expanded understanding of Cathepsin-L in disease contexts. Park et al. (2025) demonstrated that Cathepsin-L inhibition mitigates cancer-associated muscle wasting while enhancing anti-PD-L1 immunotherapy efficacy, identifying it as a dual therapeutic target in oncology. Han et al. (2025) established that lysosomal acidity and Cathepsin-L activate eosinophils through arginine metabolism mediated by arginase-1, implicating the protease in allergic airway inflammation. In viral pathogenesis, Cathepsin-L has garnered attention for its role in processing SARS-CoV-2 spike protein to facilitate endosomal entry, prompting development of peptidomimetic inhibitors as antiviral candidates. In non-small cell lung cancer, Cathepsin-L promotes stem cell properties and multidrug resistance by targeting HGF activator, as reported by Shi et al. (2026).

Triple Point Biologics offers two rabbit polyclonal antibodies raised against the Cathepsin-L propeptide domain, providing tools for detection of both the zymogen and processing intermediates in Western blot, immunohistochemistry, and immunofluorescence applications.

References

  1. Park SY et al (2025) Cathepsin L as a dual-target to mitigate muscle wasting while enhancing anti-tumor efficacy of anti-PD-L1. Nat Commun. PubMed · DOI
  2. Han Y et al (2025) Lysosomal acidity and cathepsin L activate eosinophils via ARG1-mediated arginine metabolism in allergic airway inflammation. Nat Commun. PubMed · DOI
  3. Shi H et al (2026) The lysosomal cysteine protease cathepsin L promotes stemness and multidrug resistance of non-small cell lung cancer by targeting HGF activator. Mol Cell Biochem. PubMed · DOI
  4. Kumar V et al (2026) Peptidomimetic α,β-Unsaturated Ethyl Esters Are Irreversible Inactivators of Human Cathepsin L and Are Potent Inhibitors of SARS-CoV-2 in Cellular Models of COVID-19. J Med Chem. PubMed · DOI
  5. Lumi Tanaka Dino C et al (2026) Placental infection by SARS-CoV-2: exploring alternative entry pathways. Tissue Barriers. PubMed · DOI

Additional Specifications

Gene Symbol CTSL
UniProt ID P07711
Host Species Rabbit
Species Reactivity Validated- Human
Potential
Pack Size 100ug
Immunogen (Propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 18-113.
Immunogen (Catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 114-333.
Alternate Names CTSL, Procathepsin L, Cathepsin L1, EC 3.4.22.15, Major excreted protein, MEP

Frequently Asked Questions

What molecular weight bands should I expect for Cathepsin-L on Western blot?

Cathepsin-L is synthesized as a ~38-39 kDa preproenzyme, processed to a ~37 kDa proenzyme (procathepsin L), and matured through a single-chain intermediate (~30 kDa) into the active mature form, which appears as a heavy chain around 24-25 kDa and, depending on processing, a light chain around 5 kDa. In most lysates you will see a combination of the ~37 kDa proform and the ~25 kDa mature heavy chain. Secreted procathepsin L in conditioned media typically runs at 37-39 kDa due to mannose-6-phosphate glycosylation. Treat band pattern as a readout of processing state.

How do I distinguish Cathepsin-L from Cathepsin-V (CTSL2) on a blot?

Cathepsin-V (CTSL2/CTSL3) shares ~78% sequence identity with Cathepsin-L and runs at a similar molecular weight (mature form ~26 kDa). Polyclonal reagents raised against full-length or large fragments of CTSL can show cross-reactivity with CTSL2. If your tissue is thymus, testis, or cornea — where CTSL2 is enriched — include a CTSL2 knockdown or recombinant CTSL2 control to confirm specificity. siRNA knockdown of CTSL in your cell line of interest remains the most reliable specificity control. Cathepsin-B and -S run at distinct sizes and are not a typical confounder.

What dilution should I start with for Western blot?

Start at 1/1000 in 5% non-fat milk or BSA in TBST, with overnight incubation at 4°C. For lysates with low endogenous Cathepsin-L (e.g., non-secretory cell lines), titrate up to 1/500. For high-expressing samples such as macrophages, hepatocytes, or tumor lysates, 1/2000 to 1/5000 may give cleaner signal. Load 20-30 µg total protein. Because the proform and mature form differ in abundance and processing, run gels long enough to resolve the 24-37 kDa range — a 12-15% gel is recommended.

What are good positive control lysates for Cathepsin-L?

HeLa, HEK293, A549, and HepG2 express detectable endogenous Cathepsin-L and are reliable positive controls. Macrophage lines (RAW 264.7 in mouse studies; THP-1 differentiated with PMA in human) show strong expression of both pro- and mature forms. Liver, kidney, and spleen tissue lysates are robust tissue-level controls. For secreted procathepsin L, concentrated conditioned medium from serum-starved fibroblasts or transformed cells (e.g., MDA-MB-231) works well. Pair with a CTSL siRNA or CRISPR knockout lysate as a negative control to confirm band identity.

How should I prepare samples to preserve Cathepsin-L processing intermediates?

Cathepsin-L is autocatalytic and active at acidic pH, so lysates can self-digest during preparation. Lyse on ice in a neutral-pH buffer (e.g., 50 mM Tris pH 7.4, 150 mM NaCl, 1% Triton X-100) supplemented with E-64 (10 µM) or leupeptin (10 µg/mL) to inhibit cysteine protease activity, plus a broad protease inhibitor cocktail. Avoid acidic lysis buffers unless you are intentionally activating the enzyme. Boil samples in Laemmli buffer immediately. For secreted procathepsin L analysis, collect serum-free conditioned media and concentrate with TCA or 10 kDa MWCO filters.

Is this antibody validated for mouse or rat Cathepsin-L?

This lot is validated on human samples. Human CTSL shares roughly 75% identity with mouse Ctsl and 76% with rat Ctsl at the protein level, so cross-reactivity is plausible but not guaranteed depending on the epitope region. We list mouse and rat as predicted only. If you intend to use this reagent on rodent samples, run a pilot blot with a known positive tissue (mouse liver or spleen) alongside a CTSL knockout or knockdown control. Report back to us — we update reactivity claims based on customer-validated data.

Can I use this antibody for immunoprecipitation or activity-based profiling?

This antibody is validated for Western blot. It has not been formally validated for IP. Polyclonal rabbit reagents against Cathepsin-L often work for native IP because they recognize multiple epitopes, but pilot the application with 2-5 µg per mg lysate and confirm pulldown by blotting with an orthogonal antibody. For activity studies, this antibody detects total enzyme (pro + mature) and does not discriminate active from inactive species — pair with an activity-based probe such as DCG-04 if you need to quantify active Cathepsin-L.

How should I store the antibody and how stable is it?

Store at -20°C upon receipt. The antibody is supplied in PBS with 0.02% sodium azide and 50% glycerol, which keeps it liquid at -20°C and allows direct pipetting without a freeze-thaw cycle. For long-term storage beyond 12 months, aliquot and hold at -80°C. Avoid repeated freeze-thaw cycles — more than 5 cycles can degrade signal, particularly for IF applications. Do not store at 4°C beyond 1-2 weeks. If you observe precipitate, spin at 10,000 × g for 2 minutes and use the supernatant; activity is typically unaffected.

Western blot validation for RP-CathepsinL — 2 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Cathepsin-L: Propeptide domain — WB validation
WB · Panel 1 Cathepsin-L: Propeptide domain
Cathepsin-L: Catalytic domain — WB validation
WB · Panel 2 Cathepsin-L: Catalytic domain

Custom validation studies available on request — contact us.

Also known as:

  • CTSL
  • Procathepsin L
  • Cathepsin L1
  • EC 3.4.22.15
  • Major excreted protein
  • MEP
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →